Usher Syndrome gene therapy (Prime Medicine)

N/A

Report date: 2025/09/01 16:35:35

Base Information

Drug NameUsher Syndrome gene therapy (Prime Medicine)

Drug Alias NameN/A

ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsRetinitis PigmentosaUsher Syndromes

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesPrime Medicine Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsRetinitis PigmentosaUsher Syndromes

Inactive IndicationsN/A

ATC CodeN/A